2007
DOI: 10.1097/01.ccm.0000277042.31524.66
|View full text |Cite
|
Sign up to set email alerts
|

Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia*

Abstract: B-VAP occurs later during intensive care unit stay, is more frequent in previously hospitalized patients, is more often caused by methicillin-resistant S. aureus, and is independently associated with increased intensive care unit mortality.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
61
3
5

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 92 publications
(78 citation statements)
references
References 37 publications
8
61
3
5
Order By: Relevance
“…20 The mortality rate doubles if pneumonia is associated with bacteremia. [21][22][23][24] In our study, bacteremia occurred in 15% of patients with pneumonia, a rate that is equivalent to the general population. 24 The mortality rate among our patients with staphylococcal pneumonia, however, was only 9% (6 of 66) within 30 days from the onset of disease, which was similar for patients with and without bacteremia.…”
Section: Discussionmentioning
confidence: 75%
“…20 The mortality rate doubles if pneumonia is associated with bacteremia. [21][22][23][24] In our study, bacteremia occurred in 15% of patients with pneumonia, a rate that is equivalent to the general population. 24 The mortality rate among our patients with staphylococcal pneumonia, however, was only 9% (6 of 66) within 30 days from the onset of disease, which was similar for patients with and without bacteremia.…”
Section: Discussionmentioning
confidence: 75%
“…7 These striking differences in fatality rates can be explained by differences in study methods (eg matching criteria), target population (eg, age, immune status), causative microorganisms and their antibiotic susceptibility patterns, and appropriateness of antimicrobial therapy. [8][9][10][11][12][13] Other issues that might affect outcome in VAP patients, such as the role of specific nursing protocols, the value of advanced nurse practitioners in the treatment of VAP, compliance with guidelines of the Surviving Sepsis Campaign, and so on, have not been studied extensively.…”
Section: Methodsmentioning
confidence: 99%
“…ICUacquired infections account for substantial morbidity and mortality. [22][23][24][25] In addition, they contribute to a substantial economic burden mostly by increasing the length of hospitalization. 26,27 The deleterious impact of infections is greater when they are caused by multidrug-resistant pathogens or fungal species.…”
Section: Infection and Sepsismentioning
confidence: 99%